CDEK
← Mechanisms of action

Somatostatin receptor

PROTEIN FAMILYHomo sapiens

Linked proteins

Drugs acting on this target (19)

Active Pharmaceutical Ingredient Mechanism Type ▲ Approval Status API Type Mechanism of Action
octreotide (sandostatin)AgonistapprovedPeptideSomatostatin receptor agonist
somatostatinAgonistexperimentalRecombinant proteinSomatostatin receptor agonist
octreotateAntagonistexperimentalSmall moleculeSomatostatin receptor antagonist
[18f]-fet-βag-tocaBinding agentexperimentalSmall moleculeSomatostatin receptor binding agent
[68ga]ga-dota-cys-ath001Binding agentexperimentalSmall moleculeSomatostatin receptor binding agent
ga-68-dota-toc (Ga-68-dota-toc)Binding agentapprovedSmall moleculeSomatostatin receptor binding agent
lutetium dotatate lu-177 (Lutathera)Binding agentapprovedSmall moleculeSomatostatin receptor binding agent
satoreotide tetraxetanBinding agentexperimentalPeptideSomatostatin receptor binding agent
90y-smt487RadiodepletionexperimentalPeptideSomatostatin receptor radiodepletion
[68ga]ga-dota-h2d3RadiopharmaceuticalexperimentalSmall moleculeSomatostatin receptor radiopharmaceutical
[68ga]ga-nota-g5RadiopharmaceuticalexperimentalSmall moleculeSomatostatin receptor radiopharmaceutical
18f-alf-nota-octreotideRadiopharmaceuticalexperimentalPeptideSomatostatin receptor radiopharmaceutical
68ga-g21RadiopharmaceuticalexperimentalPeptideSomatostatin receptor radiopharmaceutical
68ga-r10602RadiopharmaceuticalexperimentalSmall moleculeSomatostatin receptor radiopharmaceutical
cu-64 sartateRadiopharmaceuticalexperimentalSmall moleculeSomatostatin receptor radiopharmaceutical
cu-67 sartateRadiopharmaceuticalexperimentalSmall moleculeSomatostatin receptor radiopharmaceutical
ga 68-edotreotideRadiopharmaceuticalexperimentalSmall moleculeSomatostatin receptor radiopharmaceutical
lu-177-dota-octreotideRadiopharmaceuticalexperimentalPeptideSomatostatin receptor radiopharmaceutical
satoreotide trizoxetanRadiopharmaceuticalexperimentalPeptideSomatostatin receptor radiopharmaceutical